| Group | Statistic | Placebo (N=86) | Xanomeline High Dose (N=84) | Xanomeline Low Dose (N=84) |
|---|---|---|---|---|
|
|
|
|
|
|
Group | Statistic | Placebo
(N=86) | Xanomeline High Dose
(N=84) | Xanomeline Low Dose
(N=84) |
|---|---|---|---|---|
| Age | ||||
| n | 86 | 84 | 84 | |
| Min | 52 | 56 | 51 | |
| Max | 89 | 88 | 88 | |
| Median | 76.0 | 76.0 | 77.5 | |
| Unique Subject Identifier | ⊕ | ⊕ | ⊕ | |
| Sex | ||||
| F | n | 53 | 40 | 50 |
| F | % | 61.6 | 47.6 | 59.5 |
| F | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |
| M | n | 33 | 44 | 34 |
| M | % | 38.4 | 52.4 | 40.5 |
| M | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |
| Race | ||||
| AMERICAN INDIAN OR ALASKA NATIVE | n | 0 | 1 | 0 |
| AMERICAN INDIAN OR ALASKA NATIVE | % | 0 | 1.2 | 0 |
| AMERICAN INDIAN OR ALASKA NATIVE | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |
| BLACK OR AFRICAN AMERICAN | n | 8 | 9 | 6 |
| BLACK OR AFRICAN AMERICAN | % | 9.3 | 10.7 | 7.1 |
| BLACK OR AFRICAN AMERICAN | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |
| WHITE | n | 78 | 74 | 78 |
| WHITE | % | 90.7 | 88.1 | 92.9 |
| WHITE | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |
| Ethnicity | ||||
| HISPANIC OR LATINO | n | 3 | 3 | 6 |
| HISPANIC OR LATINO | % | 3.5 | 3.6 | 7.1 |
| HISPANIC OR LATINO | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |
| NOT HISPANIC OR LATINO | n | 83 | 81 | 78 |
| NOT HISPANIC OR LATINO | % | 96.5 | 96.4 | 92.9 |
| NOT HISPANIC OR LATINO | Unique Subject Identifier | ⊕ | ⊕ | ⊕ |